A useful Dilution Tracker alternative should solve a specific research problem. This guide is published by Dilutracker, a competing service separate from dilutiontracker.com. It proposes a reader-run evaluation based on public documentation checked October 31, 2026; it does not report hands-on product testing.
Define what would justify a change
Start with one requirement: a second interpretation of a financing, evidence you can inspect, an interface that fits your research, or structured access for an internal tool. These are possible needs, not claims that either service lacks a feature. Two services agreeing on a number does not establish accuracy if both rely on the same disclosure.
Before evaluating, write a short acceptance note naming representative tickers and instruments, the disclosure cutoff you will use, the evidence you need, and the required interface or API. Check those actual tickers rather than relying on a platform-wide coverage total. A candidate passes when you can answer your chosen question with traceable evidence and usable access.
Reconcile one financing before comparing estimates
Consider this hypothetical at-the-market (ATM) program. Your research cutoff is October 30, 2026. A filing available by that date reports a $20 million authorization, $5 million in gross sales, and $15 million remaining as of September 30. The subtraction uses gross sales, not cash received after fees.
Holding the $15 million balance constant, a $3 reference price implies 5 million potential shares; a $2 reference price implies 7.5 million. Different prices explain this difference without any disagreement about remaining dollar capacity. These conditional estimates establish neither completed issuance nor future net proceeds.
Dilution Tracker’s December 13, 2022 O/S chart guide documents this remaining-ATM-capacity/current-price method. It also says that chart excludes remaining shelf capacity; that statement does not establish missing shelf coverage elsewhere in the product.
Keep one compact evidence note: the program’s identity, remaining dollar capacity and its as-of date, displayed units, reference price and price date, source filing and page or exhibit, and service update date. September 30 describes the financing balance; the filing date tells you when that disclosure became available; the service update date describes the platform’s revision. None substitutes for the others.
Reconcile any later usage disclosure available by the October 30 cutoff before judging the estimates. If one value uses a later disclosure, align both to the same evidence first. Do not add related shelf capacity to the ATM as independent issuance, or assume every registered dollar can immediately be used. Record unresolved differences rather than choosing a winner without support.
Check whether the workflow can move
Before switching, confirm whether you can recreate your required watchlist, retain permitted notes and source links, and use any needed exports or integrations under the relevant plan and license. Do not assume automatic transfer. For structured access, Dilutracker’s API documentation describes REST/MCP access, filing references, monthly unique-ticker limits, and separate licensing for customer-facing redistribution. Confirm your intended use, billing cadence, renewal and cancellation terms, quotas, and access directly through Dilutracker pricing and Dilution Tracker pricing; current competitor prices and entitlements remain unverified here.
Switch if the defined requirements pass. Keep a second source if it answers a useful remaining question. Defer if evidence or access remains unresolved. Save your acceptance note so you can revisit the decision when your research needs change. For broader product context, read Dilutracker vs Dilution Tracker; for documented competitor methods, see our Dilution Tracker review.